This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Miteva, M. A. Articles by Villoutreix, B. O. Search for Related Content PubMed PubMed Citation Articles by Miteva, M. A. Articles by Villoutreix, B. O.

Theoretical and Experimental Study of the D2194G Mutation in the C2 Domain of Coagulation Factor V

M. A. Miteva ^*, J. M. Brugge , J. Rosing , G. A. F. Nicolaes  and B. O. Villoutreix ^*

^* French National Institute of Health and Medical Research (INSERM) U428, University Paris V, 75006 Paris, France; and Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands

Correspondence: Address reprint requests to Dr. Bruno O. Villoutreix, Inserm U428, 4 Avenue de l'Observatoire, 75006 Paris, France. E-mail: villoutreix{at}pharmacie.univ-paris5.fr.

Coagulation factor V (FV) is a large plasma glycoprotein with functions in both the pro- and anticoagulant pathways. In carriers of the so-called R2-FV haplotype, the FV D2194G mutation, in the C2 membrane-binding domain, is associated with low expression levels, suggesting a potential folding/stability problem. To analyze the molecular mechanisms potentially responsible for this in vitro phenotype, we used molecular dynamics (MD) and continuum electrostatic calculations. Implicit solvent simulations were performed on the x-ray structure of the wild-type C2 domain and on a model of the D2194G mutant. Because D2194 is located next to a disulfide bond (S-S bond), MD calculations were also performed on S-S bond depleted structures. D2194 is part of a salt-bridge network and investigations of the stabilizing/destabilizing role of these ionic interactions were carried out. Five mutant FV molecules were created and the expression levels measured with the aim of assessing the tolerance to amino acid changes in this region of molecule. Analysis of the MD trajectories indicated increased flexibility in some areas and energetic comparisons suggested overall destabilization of the structure due to the D2194G mutation. This substitution causes electrostatic destabilization of the domain by 3 kcal/mol. Together these effects likely explain the lowered expression levels in R2-FV carriers.

This article has been cited by other articles:

				M. A. Miteva, P. Tuffery, and B. O. Villoutreix PCE: web tools to compute protein continuum electrostatics Nucleic Acids Res., July 1, 2005; 33(suppl_2): W372 - W375. [Abstract] [Full Text] [PDF]